CSRP2
Cysteine and glycine-rich protein 2
Also known as: CRP2, CSRP2_HUMAN, LMO5, SmLIM
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16527
- Gene
- CSRP2
- Ensembl
- ENSG00000175183
- Chromosome
- 12
- Canonical length
- 193 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
CSRP2 is a member of the CSRP family of genes, encoding a group of LIM domain proteins, which may be involved in regulatory processes important for development and cellular differentiation. CRP2 contains two copies of the cysteine-rich amino acid sequence motif (LIM) with putative zinc-binding activity, and may be involved in regulating ordered cell growth. Other genes in the family include CSRP1 and CSRP3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
193 residues, UniProt reviewed canonical sequence.
>Q16527|CSRP2
1 MPVWGGGNKC GACGRTVYHA EEVQCDGRSF HRCCFLCMVC RKNLDSTTVA IHDEEIYCKS
61 CYGKKYGPKG YGYGQGAGTL NMDRGERLGI KPESVQPHRP TTNPNTSKFA QKYGGAEKCS
121 RCGDSVYAAE KIIGAGKPWH KNCFRCAKCG KSLESTTLTE KEGEIYCKGC YAKNFGPKGF
181 GYGQGAGALV HAQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSRP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 334 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 334 nTPM
- esophagus: 96 nTPM
- kidney: 90 nTPM
- cervix: 80 nTPM
- placenta: 79 nTPM
- adipose tissue: 70 nTPM
Single-cell type
- ocular epithelial cells: 1,187 nCPM
- vascular smooth muscle cells: 542 nCPM
- müller glia: 382 nCPM
- esophageal basal cells: 355 nCPM
- cytotrophoblasts: 331 nCPM
- esophageal suprabasal cells: 280 nCPM
Immune cell
- naive CD4 T-cell: 0.2 nTPM
- neutrophil: 0.2 nTPM
- eosinophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- hypothalamus: 40 nTPM
- thalamus: 37 nTPM
- white matter: 35 nTPM
- medulla oblongata: 30 nTPM
- cerebellum: 27 nTPM
- midbrain: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.58
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CSRP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSRP2 as an antibody target. Whether an autoantibody or antibody against CSRP2 could matter depends on whether native CSRP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSRP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSRP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...